Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…
Shields Outcomes 2024 Report
How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services
Exploring AI’s Potential to Transform Specialty Pharmacy
Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population
This poster explores the impact of the pharmacy liaison-managed care model at CHRISTUS Health System on HbA1c reduction and medication adherence for patients living with diabetes with baseline A1C>9.
Shields Health Solutions Awards Two Resident Research Grants to Advance Health System Specialty Pharmacy
STOUGHTON, Mass.–(BUSINESS WIRE)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, is proud to award resident research grants in the amount of $5,000 to supplement two existing…
Pharmacist Based Coaching Within a Specialty Diabetes Center Improved Outcomes for Uncontrolled Diabetes
This poster spotlights our collaboration with UMass Memorial Health and the innovative Diabetes Care Coach program. Our certified diabetes educators and clinical pharmacists provide integrated counseling to high-risk diabetes patients.